{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10824623", "DateCompleted": {"Year": "2000", "Month": "06", "Day": "13"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0009-9236", "JournalIssue": {"Volume": "67", "Issue": "5", "PubDate": {"Year": "2000", "Month": "May"}}, "Title": "Clinical pharmacology and therapeutics", "ISOAbbreviation": "Clin Pharmacol Ther"}, "ArticleTitle": "St John's Wort: effect on CYP3A4 activity.", "Pagination": {"StartPage": "451", "EndPage": "457", "MedlinePgn": "451-7"}, "Abstract": {"AbstractText": ["St John's Wort is a widely used herbal product. Information regarding its potential for drug interactions is required for responsible treatment of patients using St John's Wort. CYP3A4 is a metabolic enzyme implicated in most clinically significant drug-drug interactions.", "To determine the in vivo effect of reagent-grade St John's Wort extract on CYP3A4 activity through evaluation of urinary 6-beta-hydroxycortisol/cortisol ratios.", "Thirteen subjects ranging in age from 18 to 25 years participated in this unblinded, multiple-dose, single-treatment before-after trial conducted in a university-based pharmacokinetics and biopharmaceutics laboratory. Each subject ingested a 300-mg tablet of reagent-grade St John's Wort extract standardized to 0.3% hypericin three times a day for 14 days. Baseline and posttreatment CYP3A4 activity was assessed with the urinary 6-beta-hydroxycortisol/cortisol ratio after a 24-hour urine collection.", "The mean +/- SD urinary 6-beta-hydroxycortisol/cortisol ratio significantly increased (P = .003) from a baseline value of 7.1 +/- 4.5 to 13 +/- 4.9. The mean +/- SD percentage increase was 114% +/- 95%, with a range from -25% to 259%. All but one subject had an increase in the ratio.", "Treatment with St John's Wort for 14 days resulted in significant increases in the urinary 6-beta-hydroxycortisol/cortisol ratio. This finding suggests that St John's Wort is an inducer of CYP3A4."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, St Agnes Hospital, University of Maryland, Baltimore, USA."}], "Identifier": [], "LastName": "Roby", "ForeName": "C A", "Initials": "CA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Anderson", "ForeName": "G D", "Initials": "GD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kantor", "ForeName": "E", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dryer", "ForeName": "D A", "Initials": "DA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Burstein", "ForeName": "A H", "Initials": "AH"}], "PublicationTypeList": ["Clinical Trial", "Controlled Clinical Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Clin Pharmacol Ther", "NlmUniqueID": "0372741", "ISSNLinking": "0009-9236"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "9035-51-2", "NameOfSubstance": "Cytochrome P-450 Enzyme System"}, {"RegistryNumber": "EC 1.-", "NameOfSubstance": "Mixed Function Oxygenases"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "CYP3A protein, human"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "Cytochrome P-450 CYP3A"}, {"RegistryNumber": "EC 1.14.14.55", "NameOfSubstance": "CYP3A4 protein, human"}, {"RegistryNumber": "WI4X0X7BPJ", "NameOfSubstance": "Hydrocortisone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": [], "DescriptorName": "Cytochrome P-450 CYP3A"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Cytochrome P-450 Enzyme System"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["urine"], "DescriptorName": "Hydrocortisone"}, {"QualifierName": [], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Mixed Function Oxygenases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Reference Values"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "5", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "6", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "5", "Day": "29", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10824623", "10.1067/mcp.2000.106793", "S0009-9236(00)44634-5"]}}], "PubmedBookArticle": []}